Lymphatica is a clinical stage medical device development company that has designed and patented the first implantable system for chronic lymphedema treatment, which will improve the quality of life of millions of patients in the world.
Chronic lymphedema is a common side effect of cancer therapies that causes chronic swelling of the limbs, pain and recurrent infections, leading to a state of chronic disability. More than 10 million people in Europe and US have lymphedema.
Lymphatica is a new hope for the patient and a new tool for healthcare specialists.
Chronic lymphedema is a common side effect of cancer therapies that causes chronic swelling of the limbs, pain and recurrent infections, leading to a state of chronic disability. More than 10 million people in Europe and US have lymphedema.
Lymphatica is a new hope for the patient and a new tool for healthcare specialists.
Investors 1
| Date | Name | Website |
| 21.11.2024 | Venture Ki... | venturekic... |
Mentions in press and media 6
| Date | Title | Description |
| 12.07.2024 | Industry experts avail resources to young companies | From the Top 10 selected startups for the Swiss Prime Site Accelerator Program, VAULTED AG, viboo and Resilientsy emerged as finalists, winning a ticked for an intensive Acceleration Programme. They would collaborate with Swiss Prime Site ... |
| 12.02.2024 | Lymphatica Medtech awarded FDA Breakthrough Device Designation | Chronic lymphedema, characterized by debilitating swelling of limbs, poses a considerable challenge for millions worldwide, particularly those who have undergone cancer treatment involving lymph node removal or damage. LymphoDrain, an inno... |
| 24.10.2023 | Startups appoint industry mavens to their board of directors | |
| 15.06.2023 | CHF 1.2M FIT Funding for Imverse, Isochronic & Lymphatica | Merging the real world and holograms Imverse revolutionizes hologram broadcasting with its cutting-edge technology. Based in Morges, this pioneering EPFL spin-off enables users to instantly broadcast their own live holograms. The technology... |
| 28.04.2023 | Swiss Accelerator: Innosuisse supports 53 companies with CHF112 million | |
| 30.03.2023 | 15 startups contest to win CHF 100,000 |